Log in to save to my catalogue

Safety and efficacy of long term asfotase alfa treatment in childhood hypophosphatasia

Safety and efficacy of long term asfotase alfa treatment in childhood hypophosphatasia

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a95b6f9c86de4bc399a634a09adbdc20

Safety and efficacy of long term asfotase alfa treatment in childhood hypophosphatasia

About this item

Full title

Safety and efficacy of long term asfotase alfa treatment in childhood hypophosphatasia

Publisher

England: BMC

Journal title

Italian journal of pediatrics, 2025-03, Vol.51 (1), p.86-6, Article 86

Language

English

Formats

Publication information

Publisher

England: BMC

More information

Scope and Contents

Contents

Hypophosphatasia (HPP) is a rare inherited disorder characterized by a deficiency of tissue-non-specific alkaline phosphatase (TNSALP) due to loss-of-function variants of the ALPL gene. HPP is characterized by an extremely variable age of onset and clinical presentation, largely depending on the type of genetic disruption. Childhood HPP commonly pr...

Alternative Titles

Full title

Safety and efficacy of long term asfotase alfa treatment in childhood hypophosphatasia

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_a95b6f9c86de4bc399a634a09adbdc20

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a95b6f9c86de4bc399a634a09adbdc20

Other Identifiers

ISSN

1824-7288

E-ISSN

1824-7288

DOI

10.1186/s13052-025-01883-2

How to access this item